By contrast, the current study demonstrates that TREM2 deficiency results in robustly enhanced intraneuronal tau phosphorylation, aggregation, and kinase dysregulation in the hTau mouse model of tauopathy, suggesting opposing roles in modulating the two cardinal hallmarks of AD pathology. This evidence concerns the gene TREM2 and tauopathy.